- Home
- AAP vs PCVX Comparison
AAP vs PCVX Comparison
Compare AAP & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAP | PCVX |
|---|---|---|
| Founded | 1929 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 6.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AAP | PCVX |
|---|---|---|
| Price | $52.50 | $46.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 20 | 7 |
| Target Price | $52.28 | ★ $101.67 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,624,327,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.89 | $27.66 |
| 52 Week High | $70.00 | $94.60 |
Technical Indicators
Market Signals| Indicator | AAP | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 51.97 |
| Support Level | $50.89 | $43.78 |
| Resistance Level | $54.19 | $48.11 |
| Average True Range (ATR) | 2.17 | 1.99 |
| MACD | 0.50 | -0.49 |
| Stochastic Oscillator | 66.54 | 42.99 |
Price Performance
Historical ComparisonAbout AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.